Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardioselective antimuscarinic agent MF-10058 in development for cardiac conduction disorders

Nov. 28, 2000

Webcasts from AHA Scientific Sessions now available

Nov. 27, 2000

Patient enrollment and initial treatment completed in PRESTO trial

Nov. 27, 2000

Preclinical data show NO-aspirin efficacy in preventing vein graft failure

Nov. 27, 2000

Novel strategy for selective myoblast proliferation explored

Nov. 24, 2000

Adenosine A1 and A3 receptor agonists protect the heart against ischemia

Nov. 24, 2000

Caspase inhibition offers new strategy for cardiomyopathy therapy

Nov. 24, 2000

Novel antiarrhythmic agents under study at Mochida

Nov. 23, 2000

Novel ester of sPLA2 inhibitor has improved oral bioavailability

Nov. 23, 2000

Irbesartan to be evaluated in clinical trial for new indication: heart failure

Nov. 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...